EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy

Olga Maria Nardone, Irene Zammarchi iD, Giovanni Santacroce iD, Subrata Ghosh, Marietta Iacucci

Cancers · 20.04.2023 · 15 (8) · 2389

DOI: 10.3390/cancers15082389 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.04.2023. Verfasst von Olga Maria Nardone und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, University Federico II of Naples, 80131 Naples, Italy. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients affected by inflammatory bowel disease (IBD) have a two-fold higher risk of developing colorectal cancer (CRC) than the general population. IBD-related CRC follows a different genetic and molecular pathogenic pathway than sporadic CRC and can be considered a complication of chronic intestinal inflammation. Since inflammation is recognised as an independent risk factor for neoplastic progression, clinicians strive to modulate and control disease, often using potent therapy agents to achieve mucosal healing and decrease the risk of colorectal cancer in IBD patients. Improved therapeutic control of inflammation, combined with endoscopic advances and early detection of pre-cancerous lesions through surveillance programs, explains the lower incidence rate of IBD-related CRC. In addition, current research is increasingly focused on translating emerging and advanced knowledge in microbiome and metagenomics into personalised, early, and non-invasive CRC screening tools that guide organ-sparing therapy in IBD patients. This review aims to summarise the existing literature on IBD-associated CRC, focusing on new insights into the alteration of the intestinal barrier and the interactions with the gut microbiome as the initial promoter. In addition, the role of OMIC techniques for precision medicine and the impact of the available IBD therapeutic armamentarium on the evolution to CRC will be discussed.

Schlagwörter

Stichwörter der Autor:innen

IBD therapyOMICcarcinogenesiscolitis-associated cancergut barrierinflammationmicrobiome

Autor:innen und Institutionen

  • Department of Public Health, University Federico II of Naples, 80131 Naples, Italy.
  • Department of Medicine, University College of Cork, T12 R229 Cork, Ireland.

ORCID-Profile: Irene Zammarchi, Giovanni Santacroce

Zitieren

APA

Nardone, O. M., Zammarchi, I., Santacroce, G., Ghosh, S., & Iacucci, M. (2023). Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy. Cancers, 15(8), 2389. https://doi.org/10.3390/cancers15082389

Vancouver

Nardone OM, Zammarchi I, Santacroce G, Ghosh S, Iacucci M. Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy. Cancers. 2023;15(8):2389. doi:10.3390/cancers15082389

BibTeX
@article{Nardone2023,
  author = {Nardone, Olga Maria and Zammarchi, Irene and Santacroce, Giovanni and Ghosh, Subrata and Iacucci, Marietta},
  title = {Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {2389},
  doi = {10.3390/cancers15082389}
}
Kostenlos starten →